Hypoglycemia in children

Pediatric Endocrinology: Obesity, Diabetes Mellitus, Insulin Resistance, and Hypoglycemia

Volumn , Issue , 2006, Pages 291-327

  Wolfsdorf, Joseph I ^a,b   Weinstein, David A ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70749105106     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (382)

1. Sokoloff L. Circulation and energy metabolism of the brain. In: Siegel G, Agranoff B, Albers R, Molinoff P, eds. Basic Neurochemistry. New York: Raven Press, 1989:565-590.
2. Menni F, de Lonlay P, Sevin C, et al. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics 2001; 107:476-479.
3. Hume R, Burchell A, Williams FL, Koh DK. Glucose homeostasis in the newborn. Early Hum Dev 2005; 81(1):95-101.
4. Bier DM, Leake RD, Haymond MW, et al. Measurement of '‘true’' glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes 1977; 26:1016-1023.
5. Hume R, Burchell A. Abnormal expression of glucose-6-phosphatase in preterm infants. Arch Dis Child 1993; 68(2):202-204.
6. Jackson L, Burchell A, McGeechan A, Hume R. An inadequate glycemic response to glucagon is linked to insulin resistance in preterm infants? Arch Dis Child Fetal Neonatal Ed 2003; 88(1):F62-F66.
7. Hume R, McGeechan A, Burchell A. Failure to detect preterm infants at risk of hypoglycemia before discharge. J Pediatr 1999; 134(4):499-502.
8. Chaussain J. Glycemic response to 24 hour fast in normal children and children with ketotic hypoglycemia. J Pediatr 1973; 82:438-443.
9. Schwartz NS, Clutter WE, Shah SD, Cryer PE. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 1987; 79(3):777-781.
10. Mitrakou A, Ryan C, Veneman T, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 1991; 260(1 Pt 1):E67-E74.
11. Liu D, Moberg E, Kollind M, Lins PE, Adamson U, Macdonald IA. Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycemia and hypoglycaemia. Diabetologia 1992; 35(3):287-290.
12. Koh T, Aynsley-Green A, Tarbit M, Eyre J. Neural dysfunction during hypoglycaemia. Arch Dis Child 1988; 63:1353-1358.
13. Cryer PE. Hypoglycemia: pathophysiology, diagnosis, and treatment. New York: Oxford University Press, 1997.
14. Shepherd PR, Kahn BB. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341(4):248-257.
15. Brown GK. Glucose transporters: structure, function and consequences of deficiency. J Inherit Metab Dis 2000; 23(3):237-246.
16. Vannucci SJ, Maher F, Simpson IA. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 1997; 21(1):2-21.
17. Simpson IA, Appel NM, Hokari M, et al. Blood-brain barrier glucose transporter: effects of hypo-and hyperglycemia revisited. J Neurochem 1999; 72(1):238-247.
18. Kumagai AK, Kang YS, Boado RJ, Pardridge WM. Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes 1995; 44(12):1399-1404.
19. Uehara Y, Nipper V, McCall AL. Chronic insulin hypoglycemia induces GLUT-3 protein in rat brain neurons. Am J Physiol 1997; 272(4 Pt 1):E716-E719.
20. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998; 14(4):263-283.
21. Settergren G, Lindblad B, Persson B. Cerebral blood flow and exchange of oxygen, glucose, ketone bodies, lactate, pyruvate, and amino acids in infants. Acta Paediatr Scand 1976; 65:343-353.
22. Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB. Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans. Am J Physiol 1995; 268(6 Pt 1):E1161-E1166.
23. VanItallie TB, Nufert TH. Ketones: metabolism’s ugly duckling. Nutr Rev 2003; 61(10):327-341.
24. Haymond MW, Sunehag A. Controlling the sugar bowl: regulation of glucose homeostasis in children. Endocrinol Metab Clin North Am 1999; 28(4):663-694.
25. McGarry JD, Leatherman GF, Foster DW. Carnitine palmitoyltransferase I The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. J Biol Chem 1978; 253(12): 4128-4136.
26. McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 1980; 49:395-420.
27. Ruderman NB, Saha AK, Kraegen EW. Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 2003; 144(12):5166-5171.
28. Mauras N, BeckRW, RuedyKJ, et al. Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of theDiabetes Research in ChildrenNetwork (Direc-Net) accuracy study. J Pediatr 2004; 144(6):770-775.
29. Tse TF, Clutter WE, Shah SD, Cryer PE. Mechanisms of postprandial glucose counter regulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion. J Clin Invest 1983; 72(1):278-286.
30. Tse TF, Clutter WE, Shah SD, Miller JP, Cryer PE. Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects. J Clin Invest 1983; 72(1):270-277.
31. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC. Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 1996; 98(2):378-385.
32. Hellerstein MK, Neese RA, Linfoot P, Christiansen M, Turner S, Letscher A. Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study. J Clin Invest 1997; 100(5):1305-1319.
33. Katz J, Tayek JA. Gluconeogenesis and the Cori cycle in 12-, 20-, and 40-h-fasted humans. Am J Physiol 1998; 275(3 Pt 1):E537-E542.
34. Sunehag AL, Treuth MS, Toffolo G, et al. Glucose production, gluconeogenesis, and insulin sensitivity in children and adolescents: an evaluation of their reproducibility. Pediatr Res 2001; 50(1):115-123.
35. Felig P, Pozefsky T, Marliss E, Cahill GF Jr. Alanine: key role in gluconeogenesis. Science 1970; 167(920):1003-1004.
36. Wolfsdorf J, Sadeghi-Nejad A, Senior B. Fat derived fuels during a 24 hour fast in children. Eur J Pediatr 1982; 138:141-144.
37. Bonnefont J, Specola N, Vassault A, et al. The fasting test in paediatrics: application to the diagnosis of pathological hypo-and hyperketotic states. Eur J Paediatr 1990; 150:80-85.
38. Bougneres PF, Ferre P. Study of ketone body kinetics in children by a combined perfusion of 13C and 2H3 tracers. Am J Physiol 1987; 253(5 Pt 1):E496-E502.
39. Haymond M, Karl I, Clarke W, Pagliara A, Santiago J. Differences in circulating gluconeogenic substrates during short-term fasting in men, women, and children. Metabolism 1982; 31:33-41.
40. Persson B, Settergren G, Dahlquist G. Cerebral arteriovenous difference of acetoacetate and d-hydroxybutyrate in children. Acta Paediatr Scand 1972; 61(3): 273-278.
41. Owen O, Morgan A, Kemp H, Sullivan J, Herrera M, Cahill G Jr. Brain metabolism during fasting. J Clin Invest 1967; 46:1589-1595.
42. Amiel S, Archibald H, Chusney G, Williams A, Gale E. Ketone infusion lowers hormonal responses to hypoglycaemia: evidence for acute cerebral utilisation of a nonglucose fuel. Clin Sci 1991; 81:189-194.
43. Haymond M, Howard C, Ben-Galim E, DeVivo D. Effects of ketosis on glucose flux in children and adults. Am J Physiol 1983; 245:E373-E378.
44. Matschinksy F. Banting lecture 1995 A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 1996; 45:223-241.
45. Aguilar-Bryan L, Bryan J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 1999; 20(2):101-135.
46. Dunne MJ, Cosgrove KE, Shepherd RM, Ammala C. Potassium channels, sulphonylurea receptors and control of insulin release. Trends Endocrinol Metab 1999; 10(4):146-152.
47. Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 2005; 115(8):2047-2058.
48. Matschinsky FM, Glaser B, Magnuson MA. Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes 1998; 47(3):307-315.
49. Shepherd RM, Cosgrove KE, O’Brien RE, Barnes PD, Ammala C, Dunne MJ. Hyperinsulinism of infancy: towards an understanding of unregulated insulin release. European Network for Research into Hyperinsulinism in Infancy. Arch Dis Child Fetal Neonatal Ed 2000; 82(2):F87-F97.
50. Dunne MJ, Cosgrove KE, Shepherd RM, Aynsley-Green A, Lindley KJ. Hyperinsulinism in infancy: from basic science to clinical disease. Physiol Rev 2004; 84(1):239-275.
51. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 1998; 338:226-230.
52. Christesen HB, Jacobsen BB, Odili S, et al. The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy. Diabetes 2002; 51(4):1240-1246.
53. Gloyn AL, Noordam K, Willemsen MA, et al. Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. Diabetes 2003; 52(9):2433-2440.
54. Cuesta-Munoz AL, Huopio H, Otonkoski T, et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes 2004; 53(8):2164-2168.
55. Froguel P, Zouali H, Vionnet N, et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 1993; 328(10):697-702.
56. McCall AL. Effects of glucose deprivation on glucose metabolism in the central nervous system. In: Frier BM, Fisher BM, eds. Hypoglycaemia and Diabetes: Clinical and Physiological Aspects. London: Edward Arnold, 1993:56-71.
57. Boyle PJ, Kempers SF, O’Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus (see comments). N Engl J Med 1995; 333(26):1726-1731.
58. Boyle PJ, Nagy RJ, O’Connor AM, Kempers SF, Yeo RA, Qualls C. Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci USA 1994; 91(20):9352-9356.
59. DeBaun MR, King AA, White N. Hypoglycemia in Beckwith-Wiedemann syndrome. Semin Perinatol 2000; 24(2):164-171.
60. Munns CF, Batch JA. Hyperinsulinism and Beckwith-Wiedemann syndrome. Arch Dis Child Fetal Neonatal Ed 2001; 84(1):F67-F69.
61. Hussain K, Cosgrove KE, Shepherd RM, et al. Hyperinsulinemic hypoglycemia in Beckwith-Wiedemann syndrome due to defects in the function of pancreatic beta-cell adenosine triphosphate-sensitive potassium channels. J Clin Endocrinol Metab 2005; 90(7):4376-4382.
62. Agus MS, Katz LE, Satin-Smith M, Meadows AT, Hintz RL, Cohen P. Non-islet-cell tumor associated with hypoglycemia in a child: successful long-term therapy with growth hormone. J Pediatr 1995; 127(3):403-407.
63. Teale JD. Non-islet cell tumour hypoglycaemia. Clin Endocrinol (Oxf) 1999; 51(2):147.
64. Gitzelmann R, Hirsig J. Infant dumping syndrome: reversal of symptoms by feeding uncooked cornstarch. Eur J Pediatr 1986; 145:504-506.
65. Rivkees SA, Crawford JD. Hypoglycemia pathogenesis in children with dumping syndrome. Pediatrics 1987; 80(6):937-942.
66. Ng DD, Ferry RJ Jr., Kelly A, Weinzimer SA, Stanley CA, Katz LE. Acarbose treatment of postprandial hypoglycemia in children after Nissen fundoplication. J Pediatr 2001; 139(6):877-879.
67. Colle E, Ulstrom R. Ketotic hypoglycemia. J Pediatr 1964; 64:632-651.
68. Senior B. Ketotic hypoglycemia. J Pediatr 1973; 82:555-556.
69. Grunt JA, Howard RO. Findings in children with ketotic hypoglycemia. Can J Ophthalmol 1972; 7(2):151-156.
70. Daly LP, Osterhoudt KC, Weinzimer SA. Presenting features of idiopathic ketotic hypoglycemia. J Emerg Med 2003; 25(1):39-43.
71. Haymond M, Karl I, Pagliara A. Ketotic hypoglycemia: an amino acid substrate limited disorder. J Clin Endocrinol Metab 1974; 38:521-530.
72. Senior B, Loridan L. Gluconeogenesis and insulin in the ketotic variety of childhood hypoglycemia and in control children. J Pediatr 1969; 74:529-539.
73. Pagliara AS, Karl IE, De Vivo DC, Feigin RD, Kipnis DM. Hypoalaninemia: a concomitant of ketotic hypoglycemia. J Clin Invest 1972; 51(6):1440-1449.
74. Wolfsdorf J, Sadeghi-Nejad A, Senior B. Hypoalaninemia and ketotic hypoglycemia: Cause or consequence? Eur J Paediatr 1982; 138:28-31.
75. Sherwin RS, Hendler RG, Felig P. Effect of ketone infusions on amino acid and nitrogen metabolism in man. J Clin Invest 1975; 55(6):1382-1390.
76. Fery F, Balasse EO. Ketone body turnover during and after exercise in overnight-fasted and starved humans. Am J Physiol 1983; 245(4):E318-E325.
77. Hansen I, Levy M, Kerr D. Differential diagnosis of hypoglycemia in children by responses to fasting and 2-deoxyglucose. Metabolism 1983; 32:960-970.
78. Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 1991; 40(2):223-226.
79. Widom B, Simonson DC. Intermittent hypoglycemia impairs glucose counter regulation. Diabetes 1992; 41(12):1597-1602.
80. Davis MR, Shamoon H. Counterregulatory adaptation to recurrent hypoglycemia in normal humans. J Clin Endocrinol Metab 1991; 73(5):995-1001.
81. Davis SN, Shavers C, Mosqueda-Garcia R, Costa F. Effects of differing antecedent hypoglycemia on subsequent counter regulation in normal humans. Diabetes 1997; 46(8):1328-1335.
82. Chaussain J, Georges P, Olive G, Job J. Glycemic response to a 24-hour fast in normal children and children with ketotic hypoglycemia II. Hormonal and metabolic changes. J Pediatr 1974; 85:776-781.
83. Dahlquist G, Gentz J, Hagenfeldt L, et al. Ketotic hypoglycemia of childhood-a clinical trial of several unifying etiological hypotheses. Acta Paediatr Scand 1979; 68(5):649-656.
84. Leonard J, Middleton B, et al. Acetoacetyl CoA thiolase deficiency presenting as ketotic hypoglycemia. Pediatr Res 1987; 21:211.
85. Berry GT, Fukao T, Mitchell GA, et al. Neonatal hypoglycaemia in severe succinyl-CoA: 3-oxoacid CoAtransferase deficiency. J Inherit Metab Dis 2001; 24(5): 587-595.
86. Weinstein DA, Correia CE, Saunders AC, Wolfsdorf JI. Hepatic glycogen synthase deficiency: an infrequently recognized cause of ketotic hypoglycemia. Molecular Genetics Metabolism 2006; 87(4): 284-288.
87. Byrne H, Tieszen K, Hollis S, Dornan T, New J. Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care 2000; 23:500-503.
88. Marks V, Teale JD. Hypoglycemia: factitious and felonious. Endocrinol Metab Clin North Am 1999; 28(3):579-601.
89. Dershewitz R, Vestal B, Maclaren NK, Cornblath M. Transient hepatomegaly and hypoglycemia. A consequence of malicious insulin administration. Am J Dis Child 1976; 130(9):998-999.
90. Hussain K, Mundy H, Aynsley-Green A, Champion M. A child presenting with disordered consciousness, hallucinations, screaming episodes and abdominal pain. Eur J Pediatr 2002; 161(2):127-129.
91. Giurgea I, Ulinski T, Touati G, et al. Factitious hyperinsulinism leading to pancreatectomy: severe forms of Munchausen syndrome by proxy. Pediatrics 2005; 116(1):e145-e148.
92. Stanley CA. Hyperinsulinism in infants and children. Pediatr Clin North Am 1997; 44(2):363-374.
93. de Lonlay P, Fournet JC, Touati G, et al. Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases. Eur J Pediatr 2002; 161(1):37-48.
94. Meissner T, Mayatepek E. Clinical and genetic heterogeneity in congenital hyperinsulinism. Eur J Pediatr 2002; 161(1):6-20.
95. Thomas PM. Genetic mutations as a cause of hyperinsulinemic hypoglycemia in children. Endocrinol Metab Clin North Am 1999; 28(3):647-656.
96. Glaser B, Thornton P, Otonkoski T, Junien C. Genetics of neonatal hyperinsulinism. Arch Dis Child Fetal Neonatal Ed 2000; 82(2):F79-F86.
97. Fournet JC, Junien C. The genetics of neonatal hyperinsulinism. Horm Res 2003; 59(suppl 1):30-34.
98. Thomas P, Cote G, Wohlik N, et al.Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995; 268:426-429.
99. Dunne M, Kane C, Shepherd R, et al. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 1997; 336:703-706.
100. Thomas P, Ye Y, Lightner E. Mutations of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet 1996; 5:1809-1812.
101. Nestorowicz A, Inagaki N, Gonoi T, et al. A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes 1997; 46(11):1743-1748.
102. Finegold D, Stanley C, Baker L. Glycemic response to glucagon during fasting hypoglycemia: an aid in the diagnosis of hyperinsulinism. J Pediatr 1980; 96:257-259.
103. Levitt Katz L, Satin-Smith M, Collett-Solberg P, et al. Insulin-like growth factor binding protein-1 levels in the diagnosis of hypoglycemia due to hyperinsulinism. J Pediatr 1997; 131:193-199.
104. de Lonlay-Debeney P, Poggi-Travert F, Fournet JC, et al. Clinical features of 52 neonates with hyperinsulinism. N Engl J Med 1999; 340(15):1169-1175.
105. Stanley CA. Advances in diagnosis and treatment of hyperinsulinism in infants and children. J Clin Endocrinol Metab 2002; 87(11):4857-4859.
106. Stanley CA, Thornton PS, Ganguly A, et al. Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. J Clin Endocrinol Metab 2004; 89(1):288-296.
107. de Lonlay P, Fournet JC, Rahier J, et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997; 100(4):802-807.
108. Verkarre V, Fournet JC, de Lonlay P, et al. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 1998; 102(7):1286-1291.
109. Ryan F, DevaneyD, JoyceC, et al.Hyperinsulinism:molecular aetiology of focal disease. Arch Dis Child 1998; 79(5):445-447.
110. Glaser B, Ryan F, Donath M, et al. Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes 1999; 48(8):1652-1657.
111. Fournet JC, Mayaud C, de Lonlay P, et al. Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11. Am J Pathol 2001; 158(6):2177-2184.
112. Rahier J, Guiot Y, Sempoux C. Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal Ed 2000; 82(2):F108-F112.
113. Thornton PS, Satin-Smith MS, Herold K, et al. Familial hyperinsulinism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant. J Pediatr 1998; 132(1):9-14.
114. Hufnagel M, Eichmann D, Stieh J, Santer R. Further evidence for a dominant form of familial persistent hyperinsulinemic hypoglycemia of infancy: a family with documented hyperinsulinemia in two generations (letter). J Clin Endocrinol Metab 1998; 83:2215-2216.
115. Stanley CA, Lieu YK, Hsu BY, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 1998; 338(19):1352-1357.
116. Zammarchi E, Filippi L, Novembre E, Donati M. Biochemical evaluation of a patient with a familial form of leucine-sensitive hypoglycemia and concomitant hyperammonemia. Metabolism 1996; 45:957-960.
117. Weinzimer S, Stanley C, Berry G, Yudkoff M, Tuchman M, Thornton P. A syndrome of congenital hyperinsulinism and hyperammonemia. J Pediatr 1997; 130:661-664.
118. Kitaura J, Miki Y, Kato H, Sakakihara Y, Yanagisawa M. Hyperinsulinaemic hypoglycaemia associated with persistent hyperammonaemia. Eur J Pediatr 1999; 158(5): 410-413.
119. Miki Y, Taki T, Ohura T, Kato H, Yanagisawa M, Hayashi Y. Novel missense mutations in the glutamate dehydrogenase gene in the congenital hyperinsulinismhyperammonemia syndrome. J Pediatr 2000; 136(1):69-72.
120. Stanley CA. Hyperinsulinism/hyperammonemia syndrome: insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism. Mol Genet Metab 2004; 81(suppl 1):S45-S51.
121. Clayton PT, Eaton S, Aynsley-Green A, et al. Hyper insulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest 2001; 108(3):457-465.
122. Eaton S, Chatziandreou I, Krywawych S, Pen S, Clayton PT, Hussain K. Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with hyperinsulinism: a novel glucose-fatty acid cycle? Biochem Soc Trans 2003; 31(Pt 6):1137-1139.
123. Molven A, Matre GE, Duran M, et al. Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes 2004; 53(1):221-227.
124. Hussain K, Clayton PT, Krywawych S, et al. Hyperinsulinism of infancy associated with a novel splice site mutation in the SCHAD gene. J Pediatr 2005; 146(5):706-708.
125. Meissner T, Otonkoski T, Feneberg R, et al. Exercise induced hypoglycaemic hyperinsulinism. Arch Dis Child 2001; 84(3):254-257.
126. Otonkoski T, Kaminen N, Ustinov J, et al. Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release. Diabetes 2003; 52(1):199-204.
127. Aynsley-Green A, Hussain K, Hall J, et al. Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed 2000; 82(2):F98-F107.
128. Lovvorn HN III, Nance ML, Ferry RJ Jr., et al. Congenital hyperinsulinism and the surgeon: lessons learned over 35 years. J Pediatr Surg 1999; 34(5):786-792; discussion 792-793.
129. Fekete CN, de Lonlay P, Jaubert F, Rahier J, Brunelle F, Saudubray JM. The surgical management of congenital hyperinsulinemic hypoglycemia in infancy. J Pediatr Surg 2004; 39(3):267-269.
130. Adzick NS, Thornton PS, Stanley CA, Kaye RD, Ruchelli E. A multidisciplinary approach to the focal form of congenital hyperinsulinism leads to successful treatment by partial pancreatectomy. J Pediatr Surg 2004; 39(3):270-275.
131. Cretolle C, de Lonlay P, Sauvat F, et al. Congenital hyperinsulinism of infancy: surgical treatment in 60 cases of focal form. Arch Pediatr 2005; 12(3):258-263.
132. Sempoux C, Guiot Y, Lefevre A, et al. Neonatal hyperinsulinemic hypoglycemia: heterogeneity of the syndrome and keys for differential diagnosis. J Clin Endocrinol Metab 1998; 83(5):1455-1461.
133. Ribeiro MJ, De Lonlay P, Delzescaux T, et al. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-l-DOPA. J Nucl Med 2005; 46(4):560-566.
134. Henwood MJ, Kelly A, Macmullen C, et al. Genotypephenotype correlations in children with congenital hyperinsulinism due to recessive mutations of the adenosine triphosphate-sensitive potassium channel genes. J Clin Endocrinol Metab 2005; 90(2):789-794.
135. www.athenadiagnostics.com.
136. Meissner T, Brune W, Mayatepek E. Persistent hyperinsulinaemic hypoglycaemia of infancy: therapy, clinical outcome and mutational analysis. Eur J Pediatr 1997; 156(10):754-757.
137. Meissner T, Wendel U, Burgard P, Schaetzle S, Mayatepek E. Long-term follow-up of 114 patients with congenital hyperinsulinism. Eur J Endocrinol 2003; 149(1):43-51.
138. Kane C, Lindley KJ, Johnson PR, et al. Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin. J Clin Invest 1997; 100(7):1888-1893.
139. Thornton P, Alter C, Levitt Katz L, Baler L, Stanley C. Short-and long-term use of octreotide in the treatment of congenital hyperinsulinisim. J Pediatr 1993; 123:637-643.
140. Lindley K, Dunne M, Kane C, et al. Ionic control of b-cell function in nesidioblastosis. A possible therapeutic role for calcium channel blockade. Arch Dis Child 1996; 74:373-378.
141. Bas F, Darendeliler F, Demirkol D, Bundak R, Saka N, Gunoz H. Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy. J Pediatr Endocrinol Metab 1999; 12(6):873-878.
142. Suprasongsin C, Suthutvoravut U, Mahachoklertwattana P, Preeyasombat C. Combined raw cornstarch and nifedipine as an additional treatment in persistent hyperinsulinemic hypoglycemia of infancy. J Med Assoc Thai 1999; 82(suppl 1):S39-S42.
143. Eichmann D, Hufnagel M, Quick P, Santer R. Treatment of hyperinsulinaemic hypoglycaemia with nifedipine. Eur J Pediatr 1999; 158(3):204-206.
144. Spitz L, Bhargava RK, Grant DB, Leonard JV. Surgical treatment of hyperinsulinaemic hypoglycaemia in infancy and childhood. Arch Dis Child 1992; 67(2):201-205.
145. Mackinnon J, Grant DB. Hypoglycaemia in congenital adrenal hyperplasia. Arch Dis Child 1977; 52(7):591-593.
146. Weise M, Mehlinger SL, Drinkard B, et al. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise. J Clin Endocrinol Metab 2004; 89(2):591-597.
147. Sadeghi-Nejad A, Senior B. Adrenomyeloneuropathy presenting as Addison’s disease in childhood. N Engl J Med 1990; 322(1):13-16.
148. Aynsley-Green A, Moncrieff MW, Ratter S, Benedict CR, Storrs CN. Isolated ACTH deficiency. Metabolic and endocrine studies in a 7-year-old boy. Arch Dis Child 1978; 53(6):499-502.
149. al Jurayyan NA. Isolated adrenocorticotropin deficiency as a rare cause of hypoglycaemia in children. Further studies and report of an additional case. Horm Res 1995; 44(5):238-240.
150. Hopwood NJ, Forsman PJ, Kenny FM, Drash AL. Hypoglycemia in hypopituitary children. Am J Dis Child 1975; 129(8):918-926.
151. Haymond MW, Karl I, Weldon VV, Pagliara AS. The role of growth hormone and cortisone on glucose and gluconeogenic substrate regulation in fasted hypopituitary children. J Clin Endocrinol Metab 1976; 42(5):846-856.
152. Carrel AL, Somers S, Lemanske RF Jr., Allen DB. Hypoglycemia and cortisol deficiency associated with lowdose corticosteroid therapy for asthma. Pediatrics 1996; 97(6 Pt 1):921-924.
153. Hollman GA, Allen DB. Overt glucocorticoid excess due to inhaled corticosteroid therapy. Pediatrics 1988; 81(3):452-455.
154. Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002; 87(6):457-461.
155. Todd GR, Acerini CL, Buck JJ, et al. Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate. Eur Respir J 2002; 19(6):1207-1209.
156. Mahachoklertwattana P, Sudkronrayudh K, Direkwattanachai C, Choubtum L, Okascharoen C. Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate. Arch Dis Child 2004; 89(11):1055-1058.
157. Lovinger R, Kaplan S, Grumbach M. Congenital hypopituitarism associated with neonatal hypoglycemia and microphallus. J Pediatr 1975; 87:1171-1181.
158. Copeland KC, Franks RC, Ramamurthy R. Neonatal hyperbilirubinemia and hypoglycemia in congenital hypopituitarism. Clin Pediatr (Phila) 1981; 20(8):523-526.
159. Kaufman FR, Costin G, Thomas DW, Sinatra FR, Roe TF, Neustein HB. Neonatal cholestasis and hypopituitarism. Arch Dis Child 1984; 59(8):787-789.
160. Wolfsdorf J, Sadeghi-Nejad A, Senior B. Hypoketonemia and age-related fasting hypoglycemia in growth hormone deficiency. Metabolism 1983; 32:457-462.
161. Aynsley-Green A, McGann A, Deshpande S. Control of intermediary metabolism in childhood with special reference to hypoglycaemia and growth hormone. Acta Paediatr Scand Suppl 1991; 377:43-52.
162. Hussain K, Hindmarsh P, Aynsley-Green A. Spontaneous hypoglycemia in childhood is accompanied by paradoxically low serum growth hormone and appropriate cortisol counterregulatory hormonal responses. J Clin Endocrinol Metab 2003; 88(8):3715-3723.
163. Crofton PM, Midgley PC. Cortisol and growth hormone responses to spontaneous hypoglycaemia in infants and children. Arch Dis Child 2004; 89(5):472-478.
164. Laron Z. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient. J Clin Endocrinol Metab 1995; 80(5): 1526-1531.
165. Orho M, Bosshard N, Buist N, et al. Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0. J Clin Invest 1998; 102:507-515.
166. Bachrach BE, Weinstein DA, Orho-Melander M, Burgess A, Wolfsdorf JI. Glycogen synthase deficiency (glycogen storage disease type 0) presenting with hyperglycemia and glucosuria: report of three new mutations. J Pediatr 2002; 140(6):781-783.
167. www.preventiongenetics.com.
168. Aynsley-Green A, Williamson DH, Gitzelmann R. The dietary treatment of hepatic glycogen synthetase deficiency. Helv Paediat Acta 1977; 32:71-75.
169. Gitzelmann R, Spycher M, Feil G, et al. Liver glycogen synthase deficiency: a rarely diagnosed entity. Eur J Pediatr 1996; 155:561-567.
170. Chen Y-T. Glycogen storage diseases. In: Scriver C, Beaudet A, Sly W, et al., eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill, 2001:1521-1555.
171. Wolfsdorf JI, Holm IA, Weinstein DA. Glycogen storage diseases. Phenotypic, genetic, and biochemical characteristics, and therapy. Endocrinol Metab Clin North Am 1999; 28(4):801-823.
172. Chen Y-T. Type 1 glycogen storage disease: kidney involvement, pathogenesis and its treatment. Pediatr Nephrol 1991; 5:71-76.
173. Wolfsdorf JI, Laffel LMB, Crigler JF Jr. Metabolic control and renal dysfunction in type I glycogen storage disease. J Inherit Metab Dis 1997; 20(4):559-568.
174. Chen Y-T, Coleman RA, Scheinman JI, Kolbeck PC, Sidbury JB. Renal disease in type glycogen storage disease. N Engl J Med 1988; 318:7-11.
175. Lee PJ, Dalton RN, Shah V, Hindmarsh PC, Leonard JV. Glomerular and tubular function in glycogen storage disease. Pediatr Nephrol 1995; 9(6):705-710.
176. Weinstein DA, Somers MJ, Wolfsdorf JI. Decreased urinary citrate excretion in type 1a glycogen storage disease. J Pediatr 2001; 138(3):378-382.
177. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997; 24(3):276-279.
178. Franco LM, Krishnamurthy V, Bali D, et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis 2005; 28(2):153-162.
179. Weinstein DA, Roy CN, FlemingMD, LodaMF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002; 100(10):3776-3781.
180. Hiraiwa H, Pan CJ, Lin B, Moses SW, Chou JY. Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b. J Biol Chem 1999; 274(9):5532-5536.
181. Gitzelmann R, Bosshard NU. Defective neutrophil and monocyte functions in glycogen storage disease type Ib: a literature review. Eur J Pediatr 1993; 152(suppl 1):S33-S38.
182. Roe TF, Coates TD, Thomas DW, Miller JH, Gilsanz V. Treatment of chronic inflammatory bowel disease in glycogen storage disease type 1b with colony-stimulating factors. N Engl J Med 1992; 326(18):1666-1669.
183. Visser G, Rake JP, Labrune P, et al. Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1. Eur J Pediatr 2002; 161(suppl 1):S83-S87.
184. Rake JP, ten Berge AM, Visser G, et al. Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flow chart. Eur J Pediatr 2000; 159(5):322-330.
185. http://medgenetics.pediatrics.duke.edu/.
186. Wolfsdorf JI, Crigler JF Jr. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease. J Pediatr Gastroenterol Nutr 1999; 29(2):136-143.
187. Chen Y-T, Cornblath M, Sidbury JB. Cornstarch therapy in type 1 glycogen storage disease. N Engl J Med 1984; 310:171-175.
188. Wolfsdorf JI, Keller RJ, Landy H, Crigler JF Jr. Glucose therapy for glycogenosis type 1 in infants: comparison of intermittent uncooked cornstarch and continuous overnight glucose feedings. J Pediatr 1990; 117(3):384-391.
189. Wolfsdorf JI, Plotkin RA, Laffel LMB, Crigler JF Jr. Continuous glucose for treatment of patients with type 1 glycogen-storage disease: comparison of the effects of dextrose and uncooked cornstarch on biochemical variables. Am J Clin Nutr 1990; 52:1043-1050.
190. Wolfsdorf JI, Ehrlich S, Landy HS, Crigler JF Jr. Optimal daytime feeding regimen to prevent postprandial hypoglycemia in type 1 glycogen storage disease. Am J Clin Nutr 1992; 56:587-592.
191. Weinstein DA, Wolfsdorf JI. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr 2002; 161(suppl 1):S35-S39.
192. Ding JH, de Barsy T, Brown BI, Coleman RA, Chen YT. Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr 1990; 116(1):95-100.
193. Van Hoof F, Hers H. The subgroups of type III glycogenosis. Eur J Biochem 1967; 2:265-270.
194. Coleman RA, Winter HS, Wolf B, Chen YT. Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features. J Inherit Metab Dis 1992; 15(6):869-881.
195. Moses S, Gadoth N, Bashan E, Ben-David E, Slonim A, Wanderman K. Neuromuscular involvement in glycogen storage disease type III. Acta Paediatr Scand 1986; 75:289-296.
196. Moses S, Wanderman K, Myroz A, Frydman M. Cardiac involvement in glycogen storage disease type III. Eur J Pediatr 1989; 148:764-766.
197. Lee PJ, Deanfield JE, Burch M, Baig K, McKenna WJ, Leonard JV. Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III. Am J Cardiol 1997; 79(6): 834-838.
198. Markowitz AJ, Chen YT, Muenzer J, Delbuono EA, Lucey MR. A man with type III glycogenosis associated with cirrhosis and portal hypertension. Gastroenterology 1993; 105(6):1882-1885.
199. Borowitz SM, Greene HL. Cornstarch therapy in a patient with type III glycogen storage disease. J Pediatr Gastroenterol Nutr 1987; 6(4):631-634.
200. Gremse DA, Bucuvalas JC, Balistreri WF. Efficacy of cornstarch therapy in type III glycogen storage disease. Am J Clin Nutr 1990; 52(4):671-674.
201. Slonim A, Weisberg C, Benke P, Evans O, Burr I. Reversal of debrancher deficiency myopathy by the use of high-protein nutrition. Ann Neurol 1982; 11:420-422.
202. Willems PJ, Gerver WJ, Berger R, Fernandes J. The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients. Eur J Pediatr 1990; 149(4):268-271.
203. Nakai A, Shigematsu Y, Takano T, Kikawa Y, Sudo M. Uncooked cornstarch treatment for hepatic phosphorylase kinase deficiency. Eur J Pediatr 1994; 153: 581-583.
204. Santer R, Steinmann B, Schaub J. Fanconi-Bickel syndrome-a congenital defect of facilitative glucose transport. Curr Mol Med 2002; 2(2):213-227.
205. Manz F, Bickel H, Brodehl J, et al. Fanconi-Bickel syndrome. Pediatr Nephrol 1987; 1(3):509-518.
206. Sakamoto O, Ogawa E, Ohura T, et al. Mutation analysis of the GLUT2 gene in patients with Fanconi-Bickel syndrome. Pediatr Res 2000; 48(5):586-589.
207. Lee PJ, Van’t Hoff WG, Leonard JV. Catch-up growth in Fanconi-Bickel syndrome with uncooked cornstarch. J Inherit Metab Dis 1995; 18(2):153-156.
208. van den Berghe G. Disorders of gluconeogenesis. J Inherit Metab Dis 1996; 19(4):470-477.
209. Steinmann B, Gitzelman R, Van den Berghe G. Disorders of fructose metabolism. In: Scriver C, Beaudet A, Sly W, et al., eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill, 2001:1489-1520.
210. Pagliara AS, Karl IE, Keating JP, Brown BI, Kipnis DM. Hepatic fructose-1,6-diphosphatase deficiency. A cause of lactic acidosis and hypoglycemia in infancy. J Clin Invest 1972; 51(8):2115-2123.
211. Kaiser UB, Hegele RA. Case report: heterogeneity of aldolase B in hereditary fructose intolerance. Am J Med Sci 1991; 302(6):364-368.
212. Kullberg-Lindh C, Hannoun C, Lindh M. Simple method for detection of mutations causing hereditary fructose intolerance. J Inherit Metab Dis 2002; 25(7):571-575.
213. Tolan DR, Brooks CC. Molecular analysis of common aldolase B alleles for hereditary fructose intolerance in North Americans. Biochem Med Metab Biol 1992; 48(1):19-25.
214. Lecavalier L, Bolli G, Cryer P, Gerich J. Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans. Am J Physiol 1989; 256(6 Pt 1):E844-E851.
215. Marks V, Teale JD. Drug-induced hypoglycemia. Endocrinol Metab Clin North Am 1999; 28(3):555-577.
216. Chan JC, CockramCS, Critchley JA. Drug-induced disorders of glucose metabolism. Mechanisms and management. Drug Saf 1996; 15(2):135-157.
217. White NJ, Warrell DA, Chanthavanich P, et al. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med 1983; 309(2):61-66.
218. White NJ, Miller KD, Marsh K, et al. Hypoglycaemia in African children with severe malaria. Lancet 1987; 1(8535):708-711.
219. Taylor TE, Molyneux ME, Wirima JJ, Fletcher KA, Morris K. Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria (published erratum appears in N Engl J Med 1989; 320(10):676). N Engl J Med 1988; 319(16):1040-1047.
220. Kawo NG, Msengi AE, Swai AB, Chuwa LM, Alberti KG, McLarty DG. Specificity of hypoglycaemia for cerebral malaria in children. Lancet 1990; 336(8713):454-457.
221. Dekker E, Hellerstein MK, Romijn JA, et al. Glucose homeostasis in children with falciparum malaria: precursor supply limits gluconeogenesis and glucose production. J Clin Endocrinol Metab 1997; 82(8):2514-2521.
222. Davis LE, Woodfin BM, Tran TQ, et al. The influenza B virus mouse model of Reyes syndrome: pathogenesis of the hypoglycaemia. Int J Exp Pathol 1993; 74(3): 251-258.
223. Corkey BE, Hale DE, Glennon MC, et al. Relationship between unusual hepatic acyl coenzyme A profiles and the pathogenesis of Reye syndrome. J Clin Invest 1988; 82(3):782-788.
224. Yoshida Y, Singh I, Singh AK, Tecklenberg FW, Brown FR III, Darby CP. Reye syndrome: rate of oxidation of fatty acids in leukocytes and serum levels of lipid peroxides. J Exp Pathol 1989; 4(3):133-139.
225. HaymondMW, Karl IE, Keating JP, DeVivo DC. Metabolic response to hypertonic glucose administration in Reye syndrome. Ann Neurol 1978; 3(3):207-215.
226. DeVivo DC, Keating JP, Haymond MW. Reye syndrome: results of intensive supportive care. J Pediatr 1975; 87(6 Pt 1):875-880.
227. Hirschhorn N, Lindenbaum J, Greenough WB III, Alam SM. Hypoglycemia in children with acute diarrhoea. Lancet 1966; 2(7455):128-132.
228. Jones R. Hypoglycaemia in children with acute diarrhea. Lancet 1966; 2:643.
229. Molla AM, Hossain M, Islam R, Bardhan PK, Sarker SA. Hypoglycemia: a complication of diarrhea in childhood. Indian Pediatr 1981; 18(3):181-185.
230. Osier FH, Berkley JA, Ross A, Sanderson F, Mohammed S, Newton CR. Abnormal blood glucose concentrations on admission to a rural Kenyan district hospital: prevalence and outcome. Arch Dis Child 2003; 88(7):621-625.
231. Bennish ML, Azad AK, Rahman O, Phillips RE. Hypoglycemia during diarrhea in childhood. Prevalence, pathophysiology, and outcome. N Engl J Med 1990; 322(19):1357-1363.
232. Slone D, Taitz L, Gilchrist G. Aspects of carbohydrate metabolism in kwashiokor: with special reference to spontaneous hypoglycaemia. Br Med J 1961; 1:32-34.
233. Hadden D. Glucose, free fatty acid, and insulin interrelations in kwashiokor and marasmus. Lancet 1967; 1:589-593.
234. Wharton B. Hypoglycaemia in children with kwashiorkor. Lancet 1970; 1:171-173.
235. Lifshitz F, Coello-Ramirez P, Gutierrez-Topete G. Monosaccharide intolerance and hypoglycemia in infants with diarrhea. I. Clinical course of 23 infants. J Pediatr 1970; 77(4):595-603.
236. Lifshitz F, Coello-Ramirez P, Gutierrez-Topete G. Monosaccharide intolerance and hypoglycemia in infants with diarrhea. II. Metabolic studies in 23 infants. J Pediatr 1970; 77(4):604-612.
237. Butler T, Arnold M, Islam M. Depletion of hepatic glycogen in the hypoglycaemia of fatal childhood diarrhoeal illnesses. Trans R Soc Trop Med Hyg 1989; 83(6):839-843.
238. Haymond MW. Diarrhea, malnutrition, euglycemia, and fuel for thought (editorial). N Engl J Med 1990; 322(19):1390-1391.
239. Shih VE. Detection of hereditary metabolic disorders involving amino acids and organic acids. Clin Biochem 1991; 24(4):301-309.
240. Saudubray JM, Nassogne MC, de Lonlay P, Touati G. Clinical approach to inherited metabolic disorders in neonates: an overview. Semin Neonatol 2002; 7(1):3-15.
241. Cheema-Dhadli S, Leznoff CC, Halperin ML. Effect of 2-methylcitrate on citrate metabolism: implications for the management of patients with propionic acidemia and methylmalonic aciduria. Pediatr Res 1975; 9(12):905-908.
242. Gibson KM, Breuer J, Nyhan WL. 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: review of 18 reported patients. Eur J Pediatr 1988; 148(3):180-186.
243. Chuang D, Shih V. Disorders of branch chain amino acid and ketoacid metabolism. In: Scriver C, Beaudet A, Sly W, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York: McGraw-Hill, 1995:1239-1277.
244. Haymond MW, Ben-Galim E, Strobel KE. Glucose and alanine metabolism in children with maple syrup urine disease. J Clin Invest 1978; 62(2):398-405.
245. Morton DH, Strauss KA, Robinson DL, Puffenberger EG, Kelley RI. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics 2002; 109(6):999-1008.
246. Holton J, Walter J, Tyfield L. Galactosemia. In: Scriver C, Beaudet A, Sly W, et al., eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill, 2001:1553-1587.
247. Holton JB, Leonard JV. Clouds still gathering over galactosaemia. Lancet 1994; 344(8932):1242-1243.
248. Zimmerman HJ, Lewis JH. Chemical-and toxin-induced hepatotoxicity. Gastroenterol Clin North Am 1995; 24(4):1027-1045.
249. Tanaka K, Ikeda Y. Hypoglycin and Jamaican vomiting sickness. Prog Clin Biol Res 1990; 321:167-184.
250. McTague JA, Forney R Jr. Jamaican vomiting sickness in Toledo, Ohio. Ann Emerg Med 1994; 23(5):1116-1118.
251. Seidner G, Alvarez MG, Yeh JI, et al. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet 1998; 18(2):188-191.
252. De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991; 325(10):703-709.
253. Jaeken J. Congenital disorders of glycosylation (CDG): update and new developments. J Inherit Metab Dis 2004; 27(3):423-426.
254. Babovic-Vuksanovic D, Patterson MC, Schwenk WF, et al. Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome. J Pediatr 1999; 135(6):775-781.
255. de Lonlay P, Cuer M, Vuillaumier-Barrot S, et al.Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: a new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose. J Pediatr 1999; 135(3):379-383.
256. Yoon KL, Ernst SG, Rasmussen C, Dooling EC, Aprille JR. Mitochondrial disorder associated with newborn cardiopulmonary arrest. Pediatr Res 1993; 33(5):433-440.
257. Maaswinkel-Mooij PD, Van den Bogert C, Scholte HR, Onkenhout W, Brederoo P, Poorthuis BJ. Depletion of mitochondrial DNA in the liver of a patient with lactic acidemia and hypoketotic hypoglycemia. J Pediatr 1996; 128(5 Pt 1):679-683.
258. Freckman M-L, Thorburn D, Kirby D, et al. Mitochondrial electron transport chain defect presenting as hypoglycemia. J Pediatr 1997; 130:431-436.
259. Mochel F, Slama A, Touati G, et al. Respiratory chain defects may present only with hypoglycemia. J Clin Endocrinol Metab 2005; 90(6):3780-3785.
260. Uchigata Y, Eguchi Y, Takayama-Hasumi S, Omori Y. Insulin autoimmune syndrome (Hirata disease): clinical features and epidemiology in Japan. Diabetes Res Clin Pract 1994; 22(2-3):89-94.
261. Redmon JB, Nuttall FQ. Autoimmune hypoglycemia. Endocrinol Metab Clin North Am 1999; 28(3):603-618.
262. Uchigata Y, Kuwata S, Tsushima T, et al. Patients with Graves’ disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB10406. J Clin Endocrinol Metab 1993; 77(1):249-254.
263. Dozio N, Scavini M, Beretta A, et al. Imaging of the buffering effect of insulin antibodies in the autoimmune hypoglycemic syndrome. J Clin Endocrinol Metab 1998; 83(2):643-648.
264. Basu A, Service FJ, Yu L, Heser D, Ferries LM, Eisenbarth G. Insulin autoimmunity and hypoglycemia in seven white patients. Endocr Pract 2005; 11(2):97-103.
265. Rinaldo P, Raymond K, al-Odaib A, Bennett MJ. Clinical and biochemical features of fatty acid oxidation disorders. Curr Opin Pediatr 1998; 10(6):615-621.
266. Roe C, Ding J. Mitochondrial fatty acid oxidation disorders. In: Scriver C, Beaudet A, Sly W, et al., eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill, 2001:2297-2326.
267. Saudubray JM, Martin D, de Lonlay P, et al. Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 1999; 22(4):488-502.
268. Hale D, Bennett M. Fatty acid oxidation disorders: a new class of metabolic diseases. J Pediatr 1992; 121:1-11.
269. Stanley CA. Carnitine deficiency disorders in children. Ann NY Acad Sci 2004; 1033:42-51.
270. Olpin SE, Allen J, Bonham JR, et al. Features of carnitine palmitoyltransferase type I deficiency. J Inherit Metab Dis 2001; 24(1):35-42.
271. Bonnefont JP, Demaugre F, Prip-Buus C, et al. Carnitine palmitoyltransferase deficiencies. Mol Genet Metab 1999; 68(4):424-440.
272. Frerman F, Goodman S. Defects of electron transfer flavoproteins and electron transfer flavoproteinubiquinone oxidoreductase: glutaric acidemia type II. In: Scriver C, Beaudet A, Sly W, et al., eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York: McGraw-Hill, 2001:2357-2366.
273. Bennett MJ, Sherwood WG. 3-Hydroxydicarboxylic and 3-ketodicarboxylic aciduria in three patients: evidence for a new defect in fatty acid oxidation at the level of 3-ketoacyl-CoA thiolase. Clin Chem 1993; 39(5):897-901.
274. Kamijo T, Indo Y, Souri M, et al. Medium chain 3-ketoacyl-coenzyme A thiolase deficiency: a new disorder of mitochondrial fatty acid beta-oxidation. Pediatr Res 1997; 42(5):569-576.
275. Mitchell G, Fukao T. Inborn errors of ketone body metabolism. In: Scriver C, Beaudet A, Sly W, et al., eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001:2327-2356.
276. Bohm N, Uy J, Kiessling M, Lehnert W. Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two newborn brothers. II. Morphology and pathogenesis. Eur J Pediatr 1982; 139(1):60-65.
277. Hug G, Bove KE, Soukup S. Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II. N Engl J Med 1991; 325(26):1862-1864.
278. Oey NA, den Boer ME, Wijburg FA, et al. Long-chain fatty acid oxidation during early human development. Pediatr Res 2005; 57(6):755-759.
279. North KN, Hoppel CL, De Girolami U, Kozakewich HP, Korson MS. Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys. J Pediatr 1995; 127(3):414-420.
280. Boles RG, Buck EA, Blitzer MG, et al. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. J Pediatr 1998; 132(6):924-933.
281. Orlowski JP. Whatever happened to Reye’s syndrome? Did it ever really exist? Crit Care Med 1999; 27(8):1582-1587.
282. Alonso EM. Acute liver failure in children: the role of defects in fatty acid oxidation. Hepatology 2005; 41(4):696-699.
283. Treem WR, Witzleben CA, Piccoli DA, et al. Mediumchain and long-chain acyl CoA dehydrogenase deficiency: clinical, pathologic and ultrastructural differentiation from Reye’s syndrome. Hepatology 1986; 6(6):1270-1278.
284. Stanley C, DeLeeuw S, Coates P, et al. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol 1991; 30:709-716.
285. Rinaldo P, O’Shea J, Coates P, Hale D, Stanley C, Tanaka K. Medium-chain acyl-CoA dehydrogenase deficiency. Diagnosis by stable isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionylglycine. N Engl J Med 1988; 319:1308-1313.
286. Van Hove J, Zhang W, Kahler S, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Diagnosis by acylcarnitine analysis in blood. Am J Hum Genet 1993:958-966.
287. Millington D. Newborn screening for metabolic diseases. American Scientist 2002; 90:40-47.
288. Morris A, Thekekara A, Wilks Z, Clayton P, Leonard J, Aynsley-Green A. Evaluation of fasts for investigating hypoglycaemia or suspected metabolic disease. Arch Dis Child 1996; 75:115-119.
289. Ziadeh R, Hoffman EP, Finegold DN, et al. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies. Pediatr Res 1995; 37(5):675-678.
290. Seymour CA, Thomason MJ, Chalmers RA, et al. Newborn screening for inborn errors of metabolism: a systematic review. Health Technol Assess 1997; 1(11):1-95.
291. Shekhawat PS, Matern D, Strauss AW. Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management. Pediatr Res 2005; 57(5 Pt 2):78R-86R.
292. Parini R, Garavaglia B, Saudubray JM, et al. Clinical diagnosis of long-chain acyl-coenzyme A-dehydrogenase deficiency: use of stress and fat-loading tests. J Pediatr 1991; 119(1 Pt 1):77-80.
293. Thakker RV. Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 2000; 29(3):541-567.
294. Trajanoski Z, Brunner GA, Gfrerer RJ, Wach P, Pieber TR. Accuracy of home blood glucose meters during hypoglycemia. Diabetes Care 1996; 19(12): 1412-1415.
295. Ho HT, Yeung WK, Young BW. Evaluation of '‘point of care’' devices in the measurement of low blood glucose in neonatal practice. Arch Dis Child Fetal Neonatal Ed 2004; 89(4):F356-F359.
296. Antunes JD, Geffner ME, Lippe BM, Landaw EM. Childhood hypoglycemia: differentiating hyperinsulinemic from nonhyperinsulinemic causes. J Pediatr 1990; 116(1):105-108.
297. Cryer PE. Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 1994; 43(11):1378-1389.
298. Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997; 46(2):271-286.
299. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003; 26(6):1902-1912.
300. Bulsara MK, Holman CD, Davis EA, Jones TW. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care 2004; 27(10):2293-2298.
301. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2004; 350(22):2272-2279.
302. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973; 182(108):171-173.
303. Bolli G, Calabrese G, De Feo P, et al. Lack of glucagon response in glucose counter-regulation in type 1 (insulin-dependent) diabetics: absence of recovery after prolonged optimal insulin therapy. Diabetologia 1982; 22(2):100-105.
304. Cryer PE. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle. Diabetes 1992; 41(3):255-260.
305. Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 1993; 91(3):819-828.
306. Aman J, Karlsson I, Wranne L. Symptomatic hypoglycaemia in childhood diabetes: a population-based questionnaire study. Diabet Med 1989; 6(3):257-261.
307. Bergada I, Suissa S, Dufresne J, Schiffrin A. Severe hypoglycemia in IDDM children. Diabetes Care 1989; 12(4):239-244.
308. Egger M, Gschwend S, Smith GD, Zuppinger K. Increasing incidence of hypoglycemic coma in children with IDDM. Diabetes Care 1991; 14(11):1001-1005.
309. Bhatia V, Wolfsdorf JI. Severe hypoglycemia in youth with insulin-dependent diabetes mellitus: frequency and causative factors. Pediatrics 1991; 88(6):1187-1193.
310. Limbert C, Schwingshandl J, Haas J, Roth R, Borkenstein M. Severe hypoglycemia in children and adolescents with IDDM: frequency and associated factors. J Diabetes Complications 1993; 7(4):216-220.
311. Bognetti F, Brunelli A, Meschi F, Viscardi M, Bonfanti R, Chiumello G. Frequency and correlates of severe hypoglycaemia in children and adolescents with diabetes mellitus. Eur J Pediatr 1997; 156(8):589-591.
312. Jacobson AM, Hauser ST, Wolfsdorf JI, et al. Psychologic predictors of compliance in children with recent onset of diabetes mellitus. J Pediatr 1987; 110(5):805-811.
313. Hepburn DA, Deary IJ, Frier BM, Patrick AW, Quinn JD, Fisher BM. Symptoms of acute insulin-induced hypoglycemia in humans with and without IDDM. Factoranalysis approach. Diabetes Care 1991; 14(11):949-957.
314. Tupola S, Rajantie J. Documented symptomatic hypoglycaemia in children and adolescents using multiple daily insulin injection therapy. Diabet Med 1998; 15(6):492-496.
315. McCrimmon RJ, Gold AE, Deary IJ, Kelnar CJ, Frier BM. Symptoms of hypoglycemia in children with IDDM. Diabetes Care 1995; 18(6):858-861.
316. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 28(5):1245-1249.
317. Dammacco F, Torelli C, Frezza E, Piccinno E, Tansella F. Problems of hypoglycemia arising in children and adolescents with insulin-dependent diabetes mellitus. The Diabetes Study Group of The Italian Society of Pediatric Endocrinology & Diabetes. J Pediatr Endocrinol Metab 1998; 11(suppl 1):167-176.
318. Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 1988; 318(23):1487-1492.
319. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988; 37:901-907.
320. Goldstein DE, England JD, Hess R, Rawlings SS, Walker B. A prospective study of symptomatic hypoglycemia in young diabetic patients. Diabetes Care 1981; 4(6): 601-605.
321. Macfarlane PI, Walters M, Stutchfield P, Smith CS. A prospective study of symptomatic hypoglycaemia in childhood diabetes. Diabet Med 1989; 6(7):627-630.
322. Daneman D, Frank M, Perlman K, Tamm J, Ehrlich R. Severe hypoglycemia in children with insulin-dependent diabetes mellitus: frequency and predisposing factors. J Pediatr 1989; 115(5 Pt 1):681-685.
323. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994; 125(2):177-188.
324. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999; 22(11):1779-1784.
325. Ryan C, Becker D. Hypoglycemia in children with type 1 diabetes mellitus: risk factors, cognitive function, and management. Endocrinol Metab Clin North Am 1999; 28:883-900.
326. Pramming S, Thorsteinsson B, Theilgaard A, Pinner EM, Binder C. Cognitive function during hypoglycaemia in type I diabetes mellitus. Br Med J (Clin Res Ed) 1986; 292(6521):647-650.
327. Clarke WL, Gonder-Frederick A, Snyder AL, Cox DJ. Maternal fear of hypoglycemia in their children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab 1998; 11(suppl 1):189-194.
328. Frier BM, Matthews DM, Steel JM, Duncan LJ. Driving and insulin-dependent diabetes. Lancet 1980; 1(8180): 1232-1234.
329. Songer TJ, LaPorte RE, Dorman JS, et al. Motor vehicle accidents and IDDM. Diabetes Care 1988; 11(9):701-707.
330. Ratner RE, Whitehouse FW. Motor vehicles, hypoglycemia, and diabetic drivers. Diabetes Care 1989; 12(3):217-222.
331. Brierley J. Brain damage due to hypoglycaemia. In: Marks V, Rose C, eds. Hypoglycaemia 2nd ed. Oxford: Blackwell Scientific Publications, 1981:488-494.
332. Aynsley-GreenA, Soltesz G. Hypoglycaemia in infancy and childhood. 1st ed. Edinburgh: Chuchill Livingstone, 1985.
333. Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990-1996. Arch Dis Child 1999; 81(4):318-323.
334. Ryan C, Vega A, Drash A. Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 1985; 75(5):921-927.
335. Rovet JF, Ehrlich RM, Hoppe M. Intellectual deficits associated with early onset of insulin-dependent diabetes mellitus in children. Diabetes Care 1987; 10(4):510-515.
336. Rovet JF, Ehrlich RM. The effect of hypoglycemic seizures on cognitive function in children with diabetes: a 7-year prospective study. J Pediatr 1999; 134(4):503-506.
337. Auer RN. Progress review: hypoglycemic brain damage. Stroke 1986; 17(4):699-708.
338. Fujioka M, Okuchi K, Hiramatsu KI, Sakaki T, Sakaguchi S, Ishii Y. Specific changes in human brain after hypoglycemic injury. Stroke 1997; 28(3):584-587.
339. Holemans X, Dupuis M, Misson N, Vanderijst JF. Reversible amnesia in a Type 1 diabetic patient and bilateral hippocampal lesions on magnetic resonance imaging (MRI). Diabet Med 2001; 18(9):761-763.
340. Chalmers J, Risk MT, Kean DM, Grant R, Ashworth B, Campbell IW. Severe amnesia after hypoglycemia. Clinical, psychometric, and magnetic resonance imaging correlations. Diabetes Care 1991; 14(10):922-925.
341. Hershey T, Perantie DC, Warren SL, Zimmerman EC, Sadler M, White NH. Frequency and timing of severe hypoglycemia affects spatial memory in children with type 1 diabetes. Diabetes Care 2005; 28(10):2372-2377.
342. Hershey T, Bhargava N, Sadler M, White NH, Craft S. Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care 1999; 22(8):1318-1324.
343. Strudwick SK, Carne C, Gardiner J, Foster JK, Davis EA, Jones TW. Cognitive functioning in children with early onset type 1 diabetes and severe hypoglycemia. J Pediatr 2005; 147(5):680-685.
344. Tupola S, Rajantie J, Akerblom HK. Experience of severe hypoglycaemia may influence both patient’s and physician’s subsequent treatment policy of insulin-dependent diabetes mellitus. Eur J Pediatr 1998; 157(8):625-627.
345. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 1987; 10(5):617-621.
346. Gonder-Frederick LA, Clarke WL, Cox DJ. The emotional, social, and behavioral implications of insulin-induced hypoglycemia. Semin Clin Neuropsychiatry 1997; 2(1):57-65.
347. Santiago JV. Nocturnal hypoglycemia in children with diabetes: an important problem revisited. J Pediatr 1997; 131(1 Pt 1):2-4.
348. Soltesz G, Acsadi G. Association between diabetes, severe hypoglycaemia, and electroencephalographic abnormalities. Arch Dis Child 1989; 64(7):992-996.
349. Dumont RH, Jacobson AM, Cole C, et al. Psychosocial predictors of acute complications of diabetes in youth. Diabet Med 1995; 12(7):612-618.
350. Verrotti A, Chiarelli F, Blasetti A, Bruni E, Morgese G. Severe hypoglycemia in insulin-dependent diabetic children treated by multiple injection insulin regimen. Acta Diabetol 1996; 33(1):53-57.
351. Mortensen HB, Hougaard P. Comparison of metabolic control in a cross-sectional study of 2873 children and adolescents with IDDM from 18 countries. The Hvidore Study Group on Childhood Diabetes (published erratum appears in Diabetes Care 1997; 20(7):1216).
352. Diabetes Care 1997; 20(5):714-720.
353. Davis EA, Keating B, Byrne GC, Russell M, Jones TW. Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care 1997; 20(1):22-25.
354. Nordfeldt S, Ludvigsson J. Severe hypoglycemia in children with IDDM. A prospective population study, 1992 Diabetes Care 1997; 20(4):497-503.
355. Davis EA, Keating B, Byrne GC, Russell M, Jones TW. Impact of improved glycaemic control on rates of hypoglycaemia in insulin dependent diabetes mellitus. Arch Dis Child 1998; 78(2):111-115.
356. Rosilio M, Cotton JB, Wieliczko MC, et al. Factors associated with glycemic control. A cross-sectional nationwide study in 2579 French children with type 1 diabetes. The French Pediatric Diabetes Group. Diabetes Care 1998; 21(7):1146-1153.
357. Tupola S, Rajantie J, Maenpaa J. Severe hypoglycaemia in children and adolescents during multiple-dose insulin therapy. Diabet Med 1998; 15(8):695-699.
358. Lteif AN, Schwenk WF II. Type 1 diabetes mellitus in early childhood: glycemic control and associated risk of hypoglycemic reactions. Mayo Clin Proc 1999; 74(3):211-216.
359. Rewers A, Chase HP, Mackenzie T, et al. Predictors of acute complications in children with type 1 diabetes. Jama 2002; 287(19):2511-2518.
360. Clarke WL, Gonder-Frederick L, Cox DJ. The frequency of severe hypoglycaemia in children with insulin-dependent diabetes mellitus. Horm Res 1996; 45(suppl 1):48-52.
361. Aynsley-Green A, Eyre J, Soltesz G. Hypoglycaemia in diabetic children. In: Frier BM, Fisher BM, eds. Hypoglycaemia Diabetes: Clinical Physiological Aspects. 1st ed. London: Edward Arnold, 1993:228-240.
362. Diabetes Control and Complications Trial Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 1991; 90(4):450-459.
363. Gale EA, Tattersall RB. Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics. Lancet 1979; 1(8125):1049-1052.
364. Winter RJ. Profiles of metabolic control in diabetic childrenfrequency of asymptomatic nocturnal hypoglycemia. Metabolism 1981; 30(7):666-672.
365. Shalwitz RA, Farkas-Hirsch R, White NH, Santiago JV. Prevalence and consequences of nocturnal hypoglycemia among conventionally treated children with diabetes mellitus. J Pediatr 1990; 116(5):685-689.
366. Porter PA, Byrne G, Stick S, Jones TW. Nocturnal hypoglycaemia and sleep disturbances in young teenagers with insulin dependent diabetes mellitus. Arch Dis Child 1996; 75(2):120-123.
367. Porter PA, Keating B, Byrne G, Jones TW. Incidence and predictive criteria of nocturnal hypoglycemia in young children with insulin-dependent diabetes mellitus. J Pediatr 1997; 130(3):366-372.
368. Beregszaszi M, Tubiana-Rufi N, Benali K, Noel M, Bloch J, Czernichow P. Nocturnal hypoglycemia in children and adolescents with insulin-dependent diabetes mellitus: prevalence and risk factors. J Pediatr 1997; 131(1 Pt 1):27-33.
369. Lopez MJ, Oyarzabal M, Barrio R, et al. Nocturnal hypoglycaemia in IDDM patients younger than 18 years. Diabet Med 1997; 14(9):772-777.
370. Tsalikian E, Mauras N, Beck RW, et al. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr 2005; 147(4):528-534.
371. Jones TW, Porter P, Sherwin RS, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998; 338(23):1657-1662.
372. Banarer S, Cryer PE. Sleep-related hypoglycemiaassociated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes 2003; 52(5):1195-1203.
373. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 1993; 42(9):1233-1237.
374. Brodows RG, Williams C, Amatruda JM. Treatment of insulin reactions in diabetics. JAMA 1984; 252(24):3378-3381.
375. Wiethop BV, Cryer PE. Alanine and terbutaline in treatment of hypoglycemia in IDDM. Diabetes Care 1993; 16(8):1131-1136.
376. Aman J, Wranne L. Treatment of hypoglycemia in diabetes: failure of absorption of glucose through rectal mucosa. Acta Paediatr Scand 1984; 73(4):560-561.
377. Aman J, Wranne L. Hypoglycaemia in childhood diabetes II. Effect of subcutaneous or intramuscular injection of different doses of glucagon. Acta Paediatr Scand 1988; 77(4):548-553.
378. Muhlhauser I, Koch J, Berger M. Pharmacokinetics and bioavailability of injected glucagon: differences between intramuscular, subcutaneous, and intravenous administration. Diabetes Care 1985; 8(1):39-42.
379. Slama G, Alamowitch C, Desplanque N, Letanoux M, Zirinis P. A new non-invasive method for treating insulinreaction: intranasal lyophylized glucagon. Diabetologia 1990; 33(11):671-674.
380. Lala VR, Vedanarayana VV, Ganesh S, Fray C, Iosub S, Noto R. Hypoglycemic hemiplegia in an adolescent with insulin-dependent diabetes mellitus: a case report and a review of the literature. J Emerg Med 1989; 7(3):233-236.
381. Wayne EA, Dean HJ, Booth F, Tenenbein M. Focal neurologic deficits associated with hypoglycemia in children with diabetes. J Pediatr 1990; 117(4):575-577.
382. Shehadeh N, Kassem J, Tchaban I, et al. High incidence of hypoglycemic episodes with neurologic manifestations in children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab 1998; 11(suppl 1):183-187.